The Non-Injectable Insulin Market is emerging as a transformative segment within diabetes care, driven by the need for painless, convenient, and patient-friendly insulin delivery systems. With diabetes prevalence rising globally and patient compliance becoming a critical challenge, pharmaceutical companies are increasingly investing in alternative insulin delivery technologies such as...